dapagliflozin api

Dapagliflozin (461432-26-8) Dapagliflozin is the first approved SGLT2 inhibitor for treating type II diabetes. It improves glycemic control as an adjunct to diet and exercise for adults with type II diabetes. Product Specifications Product Name: Dapagliflozin CAS No.: 461432-26-8 Assay: 99% Specification: CP, EP, In-house, as required Molecular Formula: C21H25ClO6 Molecular Weight: 408.88 Shelf Life: 2 Years Package: 25kg/drum Product Images